All the latest worldwide HIV and AIDS news, including treatment, prevention, and hepatitis and TB co-infections. News from our own team of writers plus articles we have selected from other sources.

aidsmap hiv & aids news

RSS

← First12345...704Next →

hiv & aids news selected from other sources

  • Hepatitis C treatment
    Gilead signs pact with 7 firms for cheap copies of hepatitis C drug
    Reuters | 14 hours ago

    Gilead's licensing agreement with firms including India's Cipla Ltd and Ranbaxy Laboratories Ltd clears the way for the launch of a cheap generic version of the drug in 91 developing countries that make up 54 percent of the total global hepatitis burden.

  • Promoting HIV testing
    New “peer navigator” program encourages at-home HIV testing
    Oakland North | 20 hours ago

    A new study using networks of friends as “peer navigators” will soon be launched in the East Bay to reach men who may be vulnerable to the AIDS virus. It’s part of an effort to make better use of confidential in-home HIV testing in order to reach at-risk populations in Oakland.

  • PrEP
    HIV-fighting intravaginal ring research nets $20M from NIH
    Fierce Drug Delivery | 20 hours ago

    The U.S. National Institutes of Health devoted $20 million to a group of institutions including Miriam Hospital in Rhode Island to develop an HIV drug-delivering intravaginal ring. The design of a successful ring is a priority in HIV research, and the sustained release of drugs the ring offers could eventually play a crucial role in HIV prevention in the developing world.

  • PrEP
    The Enfant Terrible of AIDS Activism Reaches a New Low
    Slate | 20 hours ago

    Michael Weinstein, president of the AIDS Healthcare Foundation, is many things—professional provocateur; contrarian pariah; enfant terrible of the AIDS activism world. But here’s one thing he is not: a reliable source on any matters relating to HIV/AIDS.

  • The search for a cure
    Sharon Lewin appointed to lead Doherty Institute for Infection and Immunity
    Peter Doherty Institute | 20 hours ago

    Leading infectious disease expert Professor Sharon Lewin has been appointed the inaugural Director of the Peter Doherty Institute for Infection and Immunity at the University of Melbourne.

  • HIV and criminal law
    US: County health officials get court order to stop HIV-infected man
    Seattle Times | 20 hours ago

    To stop a man with HIV who has infected eight other people in the last four years, public health officials have sought court enforcement of its order requiring him to attend counseling and treatment sessions.

  • New and experimental hepatitis C treatment
    AbbVie 3D hepatitis C regimen is well-tolerated in Phase 3 trials
    HIVandHepatitis.com | 21 hours ago

    AbbVie's 3D hepatitis C regimen containing ABT-450, ombitasvir, and dasabuvir was generally well-tolerated in the Phase 3 SAPPHIRE trials, according to a pooled analysis presented at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy last week in Washington, DC.

  • New and experimental HIV treatments
    Long acting HIV drugs to be developed
    University of Liverpool press release | 21 hours ago

    HIV drugs which only need to be taken once a month are to be developed at the University of Liverpool in a bid to overcome the problem of ‘pill fatigue’.

  • Contraception
    Advocates Call for Full Funding of Research on HIV and Contraception
    RH Reality Check | 21 hours ago

    We call on the donors to ensure the ECHO trial is fully funded without additional budget cuts or delays. ECHO is a randomized clinical trial that would look at whether the three options—Depo, Jadelle, and the copper intrauterine device—affect HIV-negative women’s risk of acquiring HIV.

  • Pharmaceutical industry
    Gilead to raise price for new hepatitis C drug above $84000
    Reuters | 21 hours ago

    The fixed-dose regimen version of Gilead Sciences Inc's $84,000 hepatitis C drug, already under fire for its record-breaking costs, is going to be even more expensive.

← First12345...937Next →

Hepatitis C news

WHO recommends global use of newest hepatitis C drugs, urges price reductions.

HIV update

Sign up for HIV update, our fortnightly news bulletin for people living with HIV in the UK.

Treatment as prevention

No-one with an undetectable viral load, gay or heterosexual, transmits HIV in two years of PARTNER study.

aidsmap news apps

Download the free aidsmap news iPhone and android apps.